Patent details

EP1232747 Title: Controlled release tablet of bupropion hydrochloride

Basic Information

Publication number:
EP1232747
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP020112462
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Controlled release tablet of bupropion hydrochloride
French Title of Invention:
Comprimés contenant du chlorhydrate de bupropione à libération contrôlée
German Title of Invention:
Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
SPC Number:

Dates

Filing date:
07/10/1999
Grant date:
28/11/2007
EP Publication Date:
28/11/2007
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/08/2002
EP B1 Publication Date:
28/11/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/10/2008
Expiration date:
07/10/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/11/2007
 
 

Name:
Biovail Laboratories International S.R.L.
Address:
Chelston Park, Building 2 Collymore Rock, St. Michael BH1, Barbados (BB)

Inventor

Name:
Seth Pawan
Address:
United States (US)

Priority

Priority Number:
184096
Priority Date:
30/10/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/32;
Filing date Document type Number of pages